Project duration: 1 Year
|
|
|
|
Each year, more than 340,000 women die in pregnancy and childbirth, with 99% of these deaths in developing countries and hemorrhage the most common cause worldwide. Bleeding can be controlled in a clinic, but we have shown that traditional midwives can use inexpensive misoprostol tablets to save lives in a woman’s home. This is where most births take place and most maternal deaths occur in the developing world--well beyond the reach of hospitals and government health services.
|
|
|
|
We help create a sustainable market for misoprostol by working with local businesses who sell it at a small profit. We work with manufacturers, assist with the regulatory process, co-sponsor policy meetings and develop educational materials. |
|
|
|
The project is uniquely scalable. Tanzania has been unable to lower maternal death rates to meet the U.N.'s 2015 goal of 75% reduction. With this drug, traditional midwives get their first effective technology and contribute to a reduction in deaths. |
|
|
When we started training for the Kigoma project, word spread. Pregnant women who knew their lives were in danger traveled 70km when they heard that we had a drug to stop bleeding after childbirth.
- Dr. Ndola Prata, Advisor, Tanzania study with traditional midwives
|
Amy Grossman,
Director, Communications and Development
Venture Strategies Innovations 2401 East Katella Avenue, Suite 400 Anaheim, CA 92806
United States
714-221-2040
|
|
|
|
|